Table 2.
Patient characteristics. Observed data (no imputations).
| Characteristics | iCBTa (n=117) | TAUb (n=122) | Missing n (%) | ||
| Sociodemographic | |||||
| Age in years, mean (SD) | 58.4 (9.0) | 60.8 (7.8) | |||
| Women, n (%) | 44 (37.6) | 36 (29.5) | |||
| Occupation, n (%) | 14 (5.8) | ||||
| Employed | 78 (66.7) | 66 (54.1) | |||
| Unemployed | 4 (3.4) | 2 (1.6) | |||
| Retired | 33 (28.2) | 37 (30.3) | |||
| Sick leave | 2 (1.7) | 1 (0.8) | |||
| Other | 0 (0.0) | 2 (1.6) | |||
| Highest level of education, n (%) | |||||
| Elementary | 22 (18.8) | 26 (21.3) | |||
| High school | 45 (38.5) | 46 (37.7) | |||
| University | 50 (42.7) | 50 (41.0) | |||
| In a relationship, n (%) | 99 (84.6) | 101 (82.8) | |||
| Children in the household, n (%) | 43 (36.8) | 34 (27.9) | |||
| Country of birth other than Sweden, n (%) | 21 (17.9) | 15 (12.3) | |||
| Smoking, n (%) | 6 (5.1) | 8 (6.6) | |||
| Alcohol, standard drinks/week (SD) | 5.7 (13.7) | 5.5 (6.1) | |||
| Leisure time physical activity, n (%) | |||||
| High activity | 19 (16.2) | 24 (19.7) | |||
| Moderate activity | 52 (44.4) | 65 (53.3) | |||
| Low activity | 37 (31.6) | 26 (21.3) | |||
| Sedentary lifestyle | 9 (7.7) | 7 (5.7) | |||
| Psychotropic medicine, n (%) | |||||
| Anxiolytics | 10 (8.5) | 7 (5.7) | |||
| Antidepressants | 11 (9.4) | 15 (12.3) | |||
| No | 98 (83.8) | 102 (83.6) | |||
| Other current counseling, n (%) | 30 (25.7) | 28 (22.9) | |||
| Medical history | |||||
| Myocardial infarction, n (%) | 19 (16.2) | 13 (10.7) | 10 (4.2) | ||
| Diabetes, n (%) | 21 (17.9) | 19 (15.6) | 9 (3.7) | ||
| Hypertension, n (%) | 42 (35.9) | 51 (41.8) | 9 (3.7) | ||
| Hyperlipidemia, n (%) | 26 (22.2) | 27 (22.1) | 9 (3.7) | ||
| Stroke, n (%) | 0 (0.0) | 4 (3.3) | 4 (1.7) | ||
| Heart failure, n (%) | 4 (3.4) | 2 (1.6) | 16 (6.7) | ||
| Cardiac status and medication | |||||
| Any angina/chest pain, n (%) | 34 (29.0) | 32 (26.2) | 30 (12.6) | ||
| Blood pressure <140/90, n (%) | 66 (56.4) | 78 (63.9) | 31 (13.0) | ||
| Body mass index, mean (SD), kg/m2 | 27.8 (5.0) | 27.4 (4.0) | 18 (7.5) | ||
| Beta-blockers at discharge, n (%) | 104 (88.9) | 106 (86.9) | 9 (3.8) | ||
| Statins at discharge, n (%) | 110 (94.0) | 115 (94.3) | 9 (3.8) | ||
| ACEc inhibitor/ARBd at discharge, n (%) | 89 (76.1) | 96 (78.7) | 9 (3.8) | ||
| DAPTe at discharge, n (%) | 107 (91.4) | 107 (87.7) | 10 (4.2) | ||
aiCBT: internet-based cognitive behavioral therapy.
bTAU: treatment as usual.
cACE:angiotensin-converting enzyme.
dARB: angiotensin receptor blocker.
eDAPT: dual antiplatelet therapy.